Skip to content

Insider · CIK 0001662321

Bass James Edward

Reports to the SEC for 1 company · IRVING, TX

Transactions

35

Companies

1

Filings

12

CIK

0001662321

Forms 4 and 5

Insider transactions

35 trades
DateCompanyValue
2020-06-10REATA PHARMACEUTICALS INCStock Option (right to buy)A Award+$67.4K
2020-06-10REATA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2019-11-20REATA PHARMACEUTICALS INCG Gift—
2019-06-12REATA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2019-06-12REATA PHARMACEUTICALS INCStock Option (right to buy)A Award+$61.3K
2019-03-05REATA PHARMACEUTICALS INCS Sale−$587K
2019-03-05REATA PHARMACEUTICALS INCG Gift—
2018-12-20REATA PHARMACEUTICALS INCP Purchase+$46.3K
2018-11-16REATA PHARMACEUTICALS INCP Purchase+$99.6K
2018-07-25REATA PHARMACEUTICALS INCP Purchase+$69.6K
2018-06-13REATA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2018-06-13REATA PHARMACEUTICALS INCStock Option (right to buy)A Award+$18.4K
2017-11-15REATA PHARMACEUTICALS INCP Purchase+$93.4K
2017-09-20REATA PHARMACEUTICALS INCG Gift—
2017-09-19REATA PHARMACEUTICALS INCG Gift—
2017-08-01REATA PHARMACEUTICALS INCP Purchase+$250K
2017-06-14REATA PHARMACEUTICALS INCStock Option (right to buy)A Award+$18.4K
2017-06-14REATA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2017-01-05REATA PHARMACEUTICALS INCClass B common stockC Conversion—
2017-01-05REATA PHARMACEUTICALS INCC Conversion—
2017-01-05REATA PHARMACEUTICALS INCC Conversion—
2017-01-05REATA PHARMACEUTICALS INCC Conversion—
2017-01-05REATA PHARMACEUTICALS INCClass B common stockC Conversion—
2017-01-05REATA PHARMACEUTICALS INCClass B common stockC Conversion—
2016-12-14REATA PHARMACEUTICALS INCP Purchase+$109K
2016-12-07REATA PHARMACEUTICALS INCStock Option (right to buy)A Award+$9,186.12
2016-12-07REATA PHARMACEUTICALS INCStock Option (right to buy)A Award—
2016-06-01REATA PHARMACEUTICALS INCC Conversion—
2016-06-01REATA PHARMACEUTICALS INCC Conversion—
2016-06-01REATA PHARMACEUTICALS INCP Purchase+$66.4K
2016-06-01REATA PHARMACEUTICALS INCClass B common stockC Conversion—
2016-06-01REATA PHARMACEUTICALS INCClass B common stockC Conversion—
2016-06-01REATA PHARMACEUTICALS INCClass B common stockC Conversion—
2016-06-01REATA PHARMACEUTICALS INCC Conversion—
2016-06-01REATA PHARMACEUTICALS INCP Purchase+$198K

Recent filings

12

Companies

1

Address

2801 GATEWAY DRIVE SUITE 150

IRVING, TX, 75063